Hypothesis 1: the A1 receptor agonist RPia decreases the frequency of SRS and hippocampal excitability in epileptic rats.
Hypothesis 2: the A1 receptor antagonist DPCPX increases the frequency of SRS and hippocampal excitability in epileptic rats.
RPia treatment resulted in 93% non-significant reduction in the frequency of seizures
DPCPX resulted in 87% significant increase in seizure rate.
One possible mechanism for seizure control relies on hippocampal excitability.